Clinomic, an Aachen, Germany-based medical technology company, raised €23M in Series B funding.
The round was led by DeepTech & Climate Fonds (DTCF) and a private family office.
The company intends to use the funds to accelerate it expansion into international markets, enhance its AI / Data capabilities, and deepen its impact on critical care.
Led by CEO Georg Griesemann, Clinomic is a a medical technology startup founded by care physicians from RWTH Aachen University Hospital. It has developed Mona, an integrated platform designed to streamline intensive care workflows, which records, organizes, analyzes, and visualizes patient and operational data, providing healthcare professionals with real-time insights to enhance decision-making.
FinSMEs
14/04/2025